Human Vaccines & Immunotherapeutics

Papers
(The H4-Index of Human Vaccines & Immunotherapeutics is 43. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-11-01 to 2024-11-01.)
ArticleCitations
COVID-19 vaccination intention in the UK: results from the COVID-19 vaccination acceptability study (CoVAccS), a nationally representative cross-sectional survey463
A qualitative insight into the perceptions and COVID-19 vaccine hesitancy among Pakistani pharmacists338
COVID-19 vaccine hesitancy: misinformation and perceptions of vaccine safety259
The efficacy and effectiveness of the COVID-19 vaccines in reducing infection, severity, hospitalization, and mortality: a systematic review205
Vaccine hesitancy in the era of COVID-19: could lessons from the past help in divining the future?170
An online survey of the attitude and willingness of Chinese adults to receive COVID-19 vaccination142
A global pandemic in the time of viral memes: COVID-19 vaccine misinformation and disinformation on TikTok138
A comprehensive review of SARS-CoV-2 vaccines: Pfizer, Moderna & Johnson & Johnson120
Extended theory of planned behavior in explaining the intention to COVID-19 vaccination uptake among mainland Chinese university students: an online survey study115
Acceptance of a COVID-19 vaccine and associated factors among pregnant women in China: a multi-center cross-sectional study based on health belief model115
The COVID-19 vaccine social media infodemic : healthcare providers’ missed dose in addressing misinformation and vaccine hesitancy107
COVID-19 vaccine hesitancy – reasons and solutions to achieve a successful global vaccination campaign to tackle the ongoing pandemic91
A systematic literature review of herpes zoster incidence worldwide85
Regulatory T cells (Tregs) and their therapeutic potential against autoimmune disorders – Advances and challenges76
Modification of a vaccine hesitancy scale for use in adult vaccinations in the United States and China71
Factors influencing COVID-19 vaccine hesitancy and acceptance among the Pakistani population70
Recombinant vaccines for COVID-1964
Vaccines and vaccination: history and emerging issues60
Delta variant (B.1.617.2) of SARS-CoV-2: Mutations, impact, challenges and possible solutions60
Online mis/disinformation and vaccine hesitancy in the era of COVID-19: Why we need an eHealth literacy revolution60
COVID-19 vaccine hesitancy: a survey in a population highly compliant to common vaccinations59
Reactive arthritis after COVID-19 vaccination59
Who should be prioritised for COVID-19 vaccination?57
SARS‑CoV-2 RBD219-N1C1: A yeast-expressed SARS-CoV-2 recombinant receptor-binding domain candidate vaccine stimulates virus neutralizing antibodies and T-cell immunity in mice56
Research trends in COVID-19 vaccine: a bibliometric analysis55
SARS-CoV-2 reinfection and implications for vaccine development55
A qualitative study exploring the relationship between mothers’ vaccine hesitancy and health beliefs with COVID-19 vaccination intention and prevention during the early pandemic months55
COVID-19 intranasal vaccines: current progress, advantages, prospects, and challenges54
COVID-19 vaccine hesitancy in Zambia: a glimpse at the possible challenges ahead for COVID-19 vaccination rollout in sub-Saharan Africa54
Immunotherapy and radiotherapy in melanoma: a multidisciplinary comprehensive review53
Willingness to accept COVID-19 vaccine among the elderly and the chronic disease population in China52
Impact of SARS-CoV-2 delta variant (B.1.617.2) in surging second wave of COVID-19 and efficacy of vaccines in tackling the ongoing pandemic52
Safety and immunogenicity of heterologous and homologous inactivated and adenoviral-vectored COVID-19 vaccine regimens in healthy adults: a prospective cohort study52
Reported COVID-19 vaccines side effects among Jordanian population: a cross sectional study50
Socio-demographic, psychological, and experiential predictors of COVID-19 vaccine hesitancy in South Korea, October-December 202048
Gender differences in the determinants of willingness to get the COVID-19 vaccine among the working-age population in Japan47
Current updates on generations, approvals, and clinical trials of CAR T-cell therapy45
Factors associated with parents’ willingness to enroll their children in trials for COVID-19 vaccination44
A longitudinal study of vaccine hesitancy attitudes and social influence as predictors of COVID-19 vaccine uptake in the US44
The mediational role of trust in the healthcare system in the association between generalized trust and willingness to get COVID-19 vaccination in Iran44
Plant-based vaccines and antibodies to combat COVID-19: current status and prospects44
Prevalence and associated factors of intention of COVID-19 vaccination among healthcare workers in China: application of the Health Belief Model44
Low coverage of COVID-19 vaccines in Africa: current evidence and the way forward43
0.062315940856934